SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010433
Filing Date
2020-08-12
Accepted
2020-08-12 16:30:58
Documents
47
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q swtx-20200630x10q.htm 10-Q 1428613
2 EX-31.1 swtx-20200630ex31143efbe.htm EX-31.1 11621
3 EX-31.2 swtx-20200630ex312d72322.htm EX-31.2 11616
4 EX-32.1 swtx-20200630ex3212966bf.htm EX-32.1 7432
5 EX-32.2 swtx-20200630ex3223d29e3.htm EX-32.2 7409
  Complete submission text file 0001558370-20-010433.txt   3523003

Data Files

Seq Description Document Type Size
6 EX-101.INS swtx-20200630.xml EX-101.INS 455843
7 EX-101.SCH swtx-20200630.xsd EX-101.SCH 24760
8 EX-101.CAL swtx-20200630_cal.xml EX-101.CAL 37820
9 EX-101.DEF swtx-20200630_def.xml EX-101.DEF 69532
10 EX-101.LAB swtx-20200630_lab.xml EX-101.LAB 248890
11 EX-101.PRE swtx-20200630_pre.xml EX-101.PRE 169922
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39044 | Film No.: 201095816
SIC: 2836 Biological Products, (No Diagnostic Substances)